Your account is not claimed yet. You can sign up with ORCID to claim your account.

Min-Bin Chen (Minbin Chen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Cell death & disease

BioMed research international

Science advances

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Bin Chen, Zhifei Li, Chengtao Gu, Hao Zheng, Yan Chen, Long Cheng
Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma. Cell death & disease 14 (2) (2023)
Min-Bin Chen, Zhifei Li, Chengtao Gu, Hao Zheng, Yan Chen, Long Cheng
Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma. Cell death & disease 14 (2) (2023)
Shi-Qing Peng, Xiao-Ren Zhu, Ming-Zhi Zhao, Yi-Fan Zhang, An-Ran Wang, Min-Bin Chen, Zhen-Yu Ye
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Cell death & disease 14 (2) (2023)
Min-Bin Chen, Zhifei Li, Chengtao Gu, Hao Zheng, Yan Chen, Long Cheng
Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma. Cell death & disease 14 (2) (2023)
Shi-Qing Peng, Xiao-Ren Zhu, Ming-Zhi Zhao, Yi-Fan Zhang, An-Ran Wang, Min-Bin Chen, Zhen-Yu Ye
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Cell death & disease 14 (2) (2023)
Shi-Qing Peng, Xiao-Ren Zhu, Ming-Zhi Zhao, Yi-Fan Zhang, An-Ran Wang, Min-Bin Chen, Zhen-Yu Ye
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Cell death & disease 14 (2) (2023)
Jing-Jing Lu, Qin Liu, Lixia Zhu, Yuanyuan Liu, Xiaoren Zhu, Shiqing Peng, Min-Bin Chen, Ping Li
Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell death & disease 13 (12) (2022)
Yan Zhang, Jun Jin, Min Tang, Ping Li, Li-Na Zhou, Yi-Ping Du, Min-Bin Chen
Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors. BioMed research international 2022 (2022)
Jing-Jing Lu, Qin Liu, Lixia Zhu, Yuanyuan Liu, Xiaoren Zhu, Shiqing Peng, Min-Bin Chen, Ping Li
Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell death & disease 13 (12) (2022)
Jing-Jing Lu, Qin Liu, Lixia Zhu, Yuanyuan Liu, Xiaoren Zhu, Shiqing Peng, Min-Bin Chen, Ping Li
Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell death & disease 13 (12) (2022)
Jing-Jing Lu, Qin Liu, Lixia Zhu, Yuanyuan Liu, Xiaoren Zhu, Shiqing Peng, Min-Bin Chen, Ping Li
Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell death & disease 13 (12) (2022)
Jing-Jing Lu, Qin Liu, Lixia Zhu, Yuanyuan Liu, Xiaoren Zhu, Shiqing Peng, Min-Bin Chen, Ping Li
Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell death & disease 13 (12) (2022)
Jin Yao, Xin-Yuan Wu, Qing Yu, Shuo-Fei Yang, Jin Yuan, Zhi-Qing Zhang, Jin-Song Xue, Qin Jiang, Min-Bin Chen, Guan-Hua Xue, Cong Cao
The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Science advances 8 (21) (2022)
Xiao-Ren Zhu, Shi-Qing Peng, Le Wang, Xiao-Yu Chen, Chun-Xia Feng, Yuan-Yuan Liu, Min-Bin Chen
Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Cell death & disease 12 (10) (2021)
Jing-Jing Lu, Ping Li, Yong Yang, Le Wang, Yan Zhang, Jia-Yao Zhu, Xiao-Ren Zhu, Min-Bin Chen
Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis. PloS one 15 (5) (2020)
Jin-Hua Gu, Xiao-Ge Wang, Li-Qiang Wang, Li-Na Zhou, Min Tang, Ping Li, Xiao-Yang Wu, Min-Bin Chen, Yan Zhang
Serum level of interleukin-35 as a potential prognostic factor for gastric cancer. Asia-Pacific journal of clinical oncology 17 (1) (2020)
Yan Zhang, Wen-Xiang Shen, Li-Na Zhou, Min Tang, Yue Tan, Chun-Xia Feng, Ping Li, Li-Qiang Wang, Min-Bin Chen
The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China. BioMed research international 2020 (2020)

Min-Bin Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Minbin Chen)

Publication Activity (10 Years)

Top Topics

Top Venues

Min-Bin Chen (Minbin Chen)